Therapeutic approaches for portal biliopathy: A systematic review

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:Raistlin_M
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Portal biliopathy(PB) is defined as the presence of biliary abnormalities in patients with non-cirrhotic/nonneoplastic extrahepatic portal vein obstruction(EHPVO) and portal cavernoma(PC). The pathogenesis of PB is due to ab extrinseco compression of bile ducts by PC and/or to ischemic damage secondary to an altered biliary vascularization in EHPVO and PC. Although asymptomatic biliary abnormalities can be frequently seen by magnetic resonance cholangiopancreatography in patients with PC(77%-100%), only a part of these(5%-38%) are symptomatic. Clinical presentation includes jaundice, cholangitis, cholecystitis, abdominal pain, and cholelithiasis. In this subset of patients is required a specific treatment. Different therapeutic approaches aimed to diminish portal hypertension and treat biliary strictures are available. In order to decompress PC, surgical porto-systemic shunt or transjugular intrahepatic porto-systemic shunt can be performed, and treatment on the biliary stenosis includes endoscopic(Endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy, balloon dilation, stone extraction, stent placement) and surgical(bilioenteric anastomosis, cholecystectomy) approaches. Definitive treatment of PB often requires multiple and combined interventions both on vascular and biliary system. Liver transplantation can be considered in patients with secondary biliary cirrhosis, recurrent cholangitis or unsuccessful control of portal hypertension. Portal biliopathy (PB) is defined as the presence of biliary abnormalities in patients with non-cirrhotic / nonneoplastic extrahepatic portal vein obstruction (EHPVO) and portal cavernoma (PC). The pathogenesis of PB is due to ab extrinseco compression of bile ducts by PC and / or to ischemic damage secondary to an altered biliary vascularization in EHPVO and PC. Although asymptomatic biliary abnormalities can be frequently seen by magnetic resonance cholangiopancreatography in patients with PC (77% -100%), only a part of these 38%) are symptomatic. Clinical presentation includes jaundice, cholangitis, cholecystitis, abdominal pain, and cholelithiasis. In this subset of patients is required a specific treatment. Different therapeutic approaches aimed to diminish portal hypertension and treat biliary strictures are available. In order to decompress PC, surgical porto-systemic shunt or transjugular intrahepatic porto-systemic shunt can be performed, and treatment on the biliary stenosis includ es endoscopic (Endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy, balloon dilation, stone extraction, stent placement) and surgical (bilioenteric anastomosis, cholecystectomy) approaches. Definitive treatment of PB often requires multiple and combined interventions both on vascular and biliary system. considered in patients with secondary biliary cirrhosis, recurrent cholangitis or unsuccessful control of portal hypertension.
其他文献
在微量注射大量肝脏mRNA之后,通过电压箝方法进行功能鉴定,两栖类卵母细胞成功地表达了AVPV1a受体。但在灌流AV4-8溶液时,却不能诱导卵母细胞产生内向振荡电流反应。提示AVP4-8不能通过AVPV1a受体而介导生理
有一个朋友问我:你觉得背叛婚姻的是男人多还是女人多?我说我没有做过调查,也不太好调查,但我初步感觉应该是男人多一些,之所以有这种感觉,倒不是我认为女人比男人要高尚多少
不知何时,我爱上了花。立春那天,我拿了一包花种子,雀跃地奔到菜园里,开始种花。奶奶扶着锄头,站在一旁,笑眯眯地分享着我的喜悦。从这以后,每天我的心都痒痒的,跑去园子里看
AIM To evaluate the therapeutic effects of ursodeoxycholic acid(UDCA) on autoimmune hepatitis(AIH).METHODS A total 136 patients who were diagnosed with AIH were
“我的天!我受不了啦!”“厕所在哪儿,厕所,我来了。”“挺……挺好吃的嘛!”……各种声音在文学社里一齐回荡着,就像一鼎正在作响的大钟一样,交织在一起。听在耳畔,颇具喜感
生本理论,即以学生为本,确切地说,是以学生的发展为教学根本,它就像一束光,为我们的教学改革指明了方向。本文的教学探索正是基于这束教学之光,就如何有效地发挥学生的主体作
<正> 词是一种内心的音响。这种内心音响有一部分(也许是主要部分)来自于词所表示的客体。不过,即使人们看不见那个对象,而只是听见其名称,在听者的头脑里也会出现一种抽象的
天籁只要停止说话,只要压下呼吸,遥远之处墙根下的一声虫鸣也可洪亮如雷、急切如鼓、延绵如潮,其音头和音尾所组成的漫长弧线,其清音声部和浊音声部的两相呼应,都朝着我的耳
Pinellia ternata lectin (PTL) extracted from the fresh juice of rhizome of pinellia ternata used as a traditional Chinese medicine facilitated the quantal relea
干细胞因子对造血系统的作用第一临床学院血液科王冠军,张福明(综述),易永林(审校)干细胞因子(Stemcellfactor,SCF)又称作肥大细胞生长因子(Mastcellgrowthfactor,MGF),Steel因子(Steelfactor,S... Stem cell factor (SCF) is also known as Mastcell